Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions

Autor: Alan Knell, Thomas Berko, Linda Lehman, Tuah Wilson, Sarah Eyangoh, Kingsley Asiedu, Ernest Opoku, Kristien Velding, Edwin Ampadu, Jérôme Robert, Estelle Marion, Bright Osei-Wusu, Annick Chauty, Edward Sarpong, William Faber, Anastasia Nsiah, Ambroise Adeye, Yaw Ampem Amoako, Marie Françoise Ardent, William Thompson, George Amofa, Richard Phillips, Line Ganlonon, John M Macdonald, Elliot Koranteng Tannor, Till F. Omansen, Raymond Omollo, Terry Treadwell, Justice Abotsi, Albert Paintsil, Nanaa Francisca Sarpong, Samuel Osei Mireku, Maxime Kiki, Raoul Saizonou, David Ofori-Adjei, Bernadette Agbavor, Godfred Sarpong, Espoir Sodjinou, Michael Ochieng Otieno, Fred Stephen Sarfo, Paul Saunderson, Aloysius Dzibordzi Loglo, Martial Kindjinou, Justice K. Boakye-Appiah, Beatrice Konadu, Arnaud Yamadjako, Didier Agossadou, Mark Forson, Tjip S. van der Werf, Sally-Ann Ohene, Elizabeth Ofori, Mathias Ndogyele, Ymkje Stienstra, Thaddaeus Egondi, Richard Asamoah-Frimpong, Joseph Ken Adu Poku, Mabel Sarpong-Duah, Joyce Mensah-Bonsu, Felicity Aboagye, Thierry Gateau, Michael Frimpong, Joseph Ofori Nyarko, Mark Wansbrough-Jones, Kabiru Mohamed Abass, Clémence Guegnard, Alexandre Tiendrebeogo, Akpolan, Jacques H. Grosset, Sandor-Adrian Klis, Naomi Adanmado Gersande

Publikováno v: The Lancet
The Lancet, 2020, 395 (10232), pp.1259-1267. ⟨10.1016/S0140-6736(20)30047-7⟩
The Lancet, Elsevier, 2020, 395 (10232), pp.1259-1267. ⟨10.1016/S0140-6736(20)30047-7⟩
The Lancet, 395(10232), 1259-1267. ELSEVIER SCIENCE INC

BACKGROUND: Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifam

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c62a9e4b664859cb8d5027e0d0cbcad
https://doi.org/10.1016/S0140-6736(20)30047-7

Randomised Trial to Compare Clarithromycin (Extended Release)-Rifampicin and Streptomycin-Rifampicin for Early, Limited Lesions of M. Ulcerans Infection

Autor: Richard O. Phillips, Jérôme Robert, K. Mohamed Abass, William Thompson, Fred Stephen Sarfo, Tuah Wilson, Godfred Sarpong, Thierry Gateau, Annick Chauty, Raymond Omollo, Michael Ochieng Otieno, Thaddaeus Wandera Egondi, Edwin O. Ampadu, Didier Agossadou, Estelle Marion, Line Ganlonon, Mark Wansbrough-Jones, Jacques Grosset, John M. Macdonald, Terry Treadwell, Paul Saunderson, Albert Paintsil, Linda Lehman, Michael Frimpong, Francisca Nanaa Sarpong, Raoul Saizonou, Alexandre Tiendrebeogo, Sally-Ann Ohene, Ymkje Stienstra, Kingsley B. Asiedu, Tjip van der Werf, Buruli Ulcer Clinical Trial Study Team

Publikováno v: SSRN Electronic Journal.

Background Buruli ulcer (Mycobacterium ulcerans infection) is a Neglected Tropical Disease characterised by severe subcutaneous necrosis, with occasional bone involvement. Being reported from 33 countries, it is most prevalent in West and Central Afr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54f596a394c70287ead37dcbfd641158
https://doi.org/10.2139/ssrn.3458507

Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease

Autor: Justice Abotsi, Kingsley Asiedu, William Thompson, Mark Forson, Mohammed K. Abass, Richard Phillips, Tuah Wilson, Mark Wansbrough-Jones, Fred S. Sarfo, Yaw Ampem Amoako

Buruli ulcer, an ulcerating skin disease caused by Mycobacterium ulcerans infection, is common in tropical areas of western Africa. We determined the clinical and microbiological responses to administration of rifampin and streptomycin for 2 weeks fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7727801aa306eec6909f39ef8344fc4
https://europepmc.org/articles/PMC3910847/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.